Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 27,913,169 $ 19,444,737
Accounts receivable 15,832 7,118
Prepaid expenses 935,498 303,178
Other current assets 527,827 576,660
Total Current Assets 29,392,326 20,331,693
Property and equipment, net 5,266,646 5,171,134
Operating lease right-of-use assets 318,393 326,085
Intangible assets, net 266,586 321,641
Total Assets 35,243,951 26,150,553
Current Liabilities    
Accounts payable 1,083,214 1,539,547
Accrued liabilities 3,152,019 3,491,740
Management and directors' fees payable 91,695 55,174
Current portion of long-term debt 822,369 841,319
Current portion of finance lease liabilities 55,335 59,930
Current portion of operating lease liabilities 157,911 179,624
Current portion of grant repayable 35,554 69,218
Total Current Liabilities 5,398,097 6,236,552
Long-term debt, net of current portion 2,219,748 2,606,885
Finance lease liabilities, net of current portion 557,338 601,967
Operating lease liabilities, net of current portion 166,085 151,828
Grant repayable, net of current portion 273,138 259,603
Total Liabilities 8,614,406 9,856,835
Common Stock    
Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 53,144,082 shares and 48,607,017 shares, respectively 53,144 48,607
Additional paid-in capital 148,468,001 126,526,239
Accumulated other comprehensive income (loss) 29,607 (59,978)
Accumulated deficit (121,817,065) (110,173,971)
Total VolitionRx Limited Stockholders' Equity 26,733,687 16,340,897
Non-controlling interest (104,142) (47,179)
Total Stockholders' Equity 26,629,545 16,293,718
Total Liabilities and Stockholders' Equity $ 35,243,951 $ 26,150,553